Purchase, Rupert published the artcileThe link between copper and Wilson’s disease, Computed Properties of 38260-01-4, the publication is Science Progress (St. Albans, United Kingdom) (2013), 96(3), 213-223, database is CAplus and MEDLINE.
A review. Wilson’s disease (hepatolenticular degeneration) is a rare inherited autosomal recessive disorder of copper metabolism leading to copper accumulation in the liver and extrahepatic organs such as the brain and cornea. Patients may present with combinations of hepatic, neurol. and psychiatric symptoms. Copper is the therapeutic target for the treatment of Wilson’s disease. Discovering the linking of copper to Wilson’s disease encompasses a study of enzootic neonatal ataxia in lambs in the 1930s, the copper-chelating properties of British Anti-Lewisite, and the chem. anal. for copper of the organs of deceased Wilson’s disease patients in the mid-to-late 1940s. Wilson’s disease is one of a number of copper-related disorders where loss of copper homeostasis as a result of genetic, nutritional or environmental factors affects human health.
Science Progress (St. Albans, United Kingdom) published new progress about 38260-01-4. 38260-01-4 belongs to catalysis-chemistry, auxiliary class Chelating Agents, name is N1,N1′-(Ethane-1,2-diyl)bis(ethane-1,2-diamine) dihydrochloride, and the molecular formula is C6H20Cl2N4, Computed Properties of 38260-01-4.
Referemce:
https://courses.lumenlearning.com/boundless-chemistry/chapter/catalysis/,
Catalysis – Wikipedia